MedTrace Logo

The Effects of Milk Proteins on Blood Pressure

NCT00471263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2024-01-24

No results posted yet for this study

Summary

The primary purpose of the study is to demonstrate a blood pressure lowering effect of CasiGold and CasiMax in subjects with high-normal blood pressure or mild hypertension. The secondary purpose is to collect human safety data after treatment with CasiGold and CasiMax, to gain insight into potential mechanisms by measurement of renin and angiotensin I and II, and to evaluate the genetic determinants of the individual BP lowering response by measurement of specific genetic polymorphisms.

Conditions

  • Blood Pressure

Interventions

DRUG

Casigold

DRUG

Casimax

DRUG

Placebo

Sponsors & Collaborators

  • DSM Food Specialties

    collaborator INDUSTRY

  • TNO

    lead OTHER

Principal Investigators

  • Esther Boelsma, PhD · TNO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-07
Primary Completion
2007-12-18
Completion
2008-02-29

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471263 on ClinicalTrials.gov